Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of diclofenac in the rat

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 2, 1997, Pages 685-690

  Torres López, Jorge E ^a   López Muñoz, Francisco J ^a   Castañeda Hernández, Gilberto ^a   Flores Murrieta, Francisco J ^a   Granados Soto, Vinicio ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC;

ANALGESIC ACTIVITY; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; DICLOFENAC; MALE; RATS; RATS, WISTAR;

EID: 0030762514     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. BJöRKMAN, R.: Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat. Acta. Anaesthesiol. Scand. 39: suppl. 103, 1-44, 1995.
2. COVINO, B. G., DUBNER, R., GYBELS, J., KOSTERLITZ, H. W., LIEBESKIND, J. C., STERNBACH, R. A., VYKLICKY, L., YAMAMURA, H. AND ZIMMERMANN, M.: Ethical standards for investigation of experimental pain in animals. Pain 9: 141-143, 1980.
3. DAYNEKA, N. L., GARG, V. AND JUSKO, W. J.: Comparison of four basic models of indirect pharmacodynamic responses. J. Pharmacokinet. Biopharm. 21: 457-478, 1993.
4. DUNAGAN, F. M., MCGILL, P. E., KELMAN, A. W. AND WHITING, B.: Quantitation of dose and concentration-effect relationship for fenclofenac in rheumatoid arthritis. Br. J. Clin. Pharmacol. 21: 409-416, 1986.
5. FAIGLE, J., BOTTCHER, I., GODBILLON, J., KRIEMLER, H., SCHLUMPF, E., STIERLIN, H. AND WINKLER, T.: A new metabolite of diclofenac sodium in human plasma. Xenobiotica 18: 1191-1197, 1988.
6. FOWLER, P., DAWES, P., JOHN, V. AND SHOTTON, P.: Plasma and synovial fluid concentrations of diclofenac sodium and its hydroxylated metabolites during once-daily administration of 100 mg slow-release formulation. Eur. J. Clin. Pharmacol., 31: 469-472, 1986.
7. FOWLER, P., SHADFORTH, M., CROOK, P. AND JOHN, V.: Plasma and synovial fluid concentrations of diclofenac sodium and its major hydroxylated metabolites during long-term treatment of rheumatoid arthritis. Eur. J. Clin. Pharmacol. 25: 389-394, 1983.
8. GABRIELSSON, J. AND WEINE, D.: Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications, pp. 561-570, Swedish Pharmaceutical Press, 1994.
9. GARG, V. AND JUSKO, W. J.: Pharmacodynamic modeling of nonsteroidal anti-inflammatory drugs: Antipyretic effect of ibuprofen. Clin. Pharmacol. Ther. 55: 87-88, 1994.
10. GRANADOS-SOTO, V., FLORES-MURRIETA, F. J., LÓPEZ-MUÑOZ, F. J., SALAZAR, L. A., VILLARREAL, J. E. ANE CASTAÑEDA-HERNÁNDEZ, G.: Relationship between paracetamol plasma levels and its analgesic effect in the rat. J. Pharm. Pharmacol. 44: 741-744, 1992.
11. GRANADOS-SOTO, V., LÓPEZ-MUÑOZ, F. J., HONG, E. AND FLORES-MURRIETA, F. J.: Relationship between pharmacokinetics and the analgesic effect of ketorolac in the rat. J. Pharmacol. Exp. Ther. 272: 352-356, 1995.
12. HOLFORD, N. H. G. AND SHEINER, L. B.: Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models. Clin. Pharmacokinet. 6: 429-453, 1981.
13. KUROWSKI, M., MENNINGER, H. AND PAULI, E.: The efficacy and relative bioavailability of diclofenac resinate in rheumatoid arthritis patients. Int. J. Clin. Pharmacol. Ther. 32: 433-440, 1994.
14. KYUKI, K.: Evaluation of non-steroidal anti-inflammatory drugs (NSAIDs) intended for use as topical anti-inflammatory drugs. Nippon Yakurigaku Zasshi 79: 461-185, 1982.
15. LÓPEZ-MUÑOZ, F. J., SALAZAR, L., CASTAÑEDA-HERNÁNDEZ, G. AND VILLARREAL, J. E.: A new model to assess analgesic activity: Pain-induced functional impairment in the rat (PIFIR). Drug Devel. Res. 28: 169-175, 1993.
16. MENASSÉ, R., HEDWELL, P., KRAETZ, J., PERICIN, C., RIESTERER, L., SALLMAN, A., ZIEL, R. AND JAQUES, R.: Pharmacological properties of diclofenac sodium and its metabolites. Scand. J. Rheumatol. 22: suppl., 5-16, 1978.
17. METZLER, C. M. AND WEINER, D. L.: PCNONLIN User Guide, Version 4.0, Software for the statistical analysis of nonlinear models on micros. SCI Software, Professional Data Analysis Software, 1992.
18. NETTER, P., BARNWORTH, B. AND ROYER-MARNOT, M. J.: Recent findings of nonsteroidal anti-inflammatory drugs in synovial fluid. Clin. Pharmacokinet. 17: 145-147, 1989.
19. OWEN, S. G., FRANCIS, H. W. AND ROBERTS, M. S.: Disappearance kineutics of solutes from synovial fluid after intra-articular injection. Br. J. Clin. Pharmacol. 38: 349-355, 1994.
20. RADERMACHER, J., JENTCH, D., SCHOLL, M. A., LUSTINETZ, T. AND FROLICH, J. C.: Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br. J. Clin. Pharmacol. 31: 537-541, 1991.
21. ROWLAND, M. AND TOZER, T. N.: Clinical Pharmacokinetics: Concepts and Applications, 2nd ed., p. 459, Lea and Febiger, Philadelphia, 1989.
22. RYHANEN, P., ADAMSKI, J., PUHAKKA, K., LEPPALUTO, J., VUOLTEENAHO, O. AND RYHANNE, J.: Postoperative pain relief in children. A comparison between caudal bupicaine and intramuscular diclofenac sodium. Anaesthesia 49: 57-61, 1994.
23. TJÖLSEN, A., BERGE, O. G., HUNSKAAR, S., ROSLAND, J. H. AND HOLE, K: The formalin test: An evaluation of the method. Pain 51: 5-17, 1992.
24. TODD, P. A. AND SORKIN, E. M.: Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 35: 244-285, 1988.
25. TONUSSI, C. R. AND FERREIRA, S. H.: Mechanism of diclofenac analgesia: Direct blockade of inflammatory sensitization. Eur. J. Pharmacol. 251: 173-179, 1994.
26. ZIMMERMANN, M.: The guidelines on ethical standards for investigation of experimental pain in animals. Pain 16: 109-110, 1983.